Research on intestinal epithelial stem cells has flourished in the last few years since their specific markers were identified. However, to exploit the potentials of those adult stem cells as a source for regenerative medicine, validation of the tissue regeneration capability of intestinal stem cells would be essential. We have recently shown that, by employing murine models of transplantation, cultured intestinal epithelial cells from the adult colon, fetal small intestine (SI), and adult SI are able to regenerate epithelia in vivo, preserving their stem cell properties. These data provide the evidence that multiple types of intestinal cells could be the source for the stem cell therapy for intestinal diseases in humans.
Introduction
With the advancement of stem cell research, there has emerged a growing interest in the use of various stem cells for the replacement therapy for human diseases. . Future progress in this research field would be directed toward the use of expanded intestinal stem cells in culture for the therapy of GI diseases in humans.
Intestinal epithelial stem cells
Intestinal epithelial tissues are unique in that they continue to self-renew throughout our lifetime. The homeostasis with this perpetual, rapid cellular turnover is governed by the tissue-resident adult stem cells sitting near the base of glandular structures called crypts [6] [7] [8] . The stem cells divide continuously, generating more committed precursor cells called transit-amplifying (TA) cells that occupy the lower part of the crypt. As cells differentiate into mature cell lineages, they migrate upward and then are exfoliated into the lumen, whereas Paneth cells, which are unique only to the small intestine (SI), migrate down to the crypt base.
The repair response to epithelial injuries caused by a variety of insults also involves the stem cell-mediated tissue regeneration 9, 10) . Acute phase response to the loss of Several regulatory signals such as the Wnt, bone morphogenic protein (BMP), and Notch pathways play important roles in both steady-state maintenance and repair response upon injury 11, 12) . Among these, the Wnt pathway is regarded as a key regulator for proliferation of the stem cells in intestinal crypts. A large body of evidence shows that intracellular signaling events triggered by the binding of Wnt proteins to their cell surface receptors are essential to maintain the crypt cell population in a proliferative state [13] [14] [15] .
In line with this, one of the Wnt target genes, a G proteincoupled receptor Lgr5, has been identified as a specific molecular marker of the stem cells of the SI and colon 1) .
Although the presence of other populations of intestinal stem cells has been proposed thereafter [16] [17] [18] , . . It is of note that these newly introduced intestinal epithelial culture methods, including the one that we developed, allow Lgr5+ putative stem cells to increase in number ex vivo.
Culturing intestinal stem cells

Transplantation of cultured stem cellcontaining epithelial organoids
Now .
Transplantation of fetal intestinal epithelial progenitor cells into adult colons
Not only for adult intestinal epithelial cells, the cutting- . This suggests that fetal SI progenitors have plasticity in regard to their fate and are able to adapt to the new microenvironment (Fig.1) .
Transplantation of small intestinal stem cells of adult origin into colons
Then, how do cultured SI cells of adult origin behave in vivo when they are transplanted back into the body? By extending our transplantation approach, we have recently assessed this 22) . SI cells were isolated from adult mice and cultured as stem cell-containing organoids as previously . They were then collected and instilled into the colonic lumen of wild-type recipient mice in which injuries were generated in advance. We found that transplanted SI 
Conclusion
In this article, I have tried to provide a brief introduction into the current status of intestinal stem cell research,
including the experimental evidence that shows feasibility of stem cell based therapy for intestinal epithelial injuries.
There are many severe GI diseases, such as congenital disorders or inflammatory bowel diseases, which affect 
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